Vegan Type II
Collagen Peptide
(Hydrolyzed wheat peptides)
Vegan Type II
Vegan Type II
Collagen Peptide
(Hydrolyzed wheat peptides)
Joint health has always been a concern for many people. Statistics show that 10% of the global population suffers from joint issues, which has led to a surge in the bone and joint health supplement market. It’s projected that the global market value will reach $26.4 billion by 2032.
Traditionally, joint health supplements are predominantly derived from animal sources, which aren’t suitable for vegetarians, limiting their options and access to high-functioning, plant-based supplements. Vollapep2™ is a groundbreaking solution in joint health supplementation—100% plant-based, vegetarian-friendly, low-dose, and fast-acting, designed to support joint health effectively.
Joint health has always been a concern for many people. Statistics show that 10% of the global population suffers from joint issues, which has led to a surge in the bone and joint health supplement market. It’s projected that the global market value will reach $26.4 billion by 2032.
Traditionally, joint health supplements are predominantly derived from animal sources, which aren’t suitable for vegetarians, limiting their options and access to high-functioning, plant-based supplements. Vollapep2™ is a groundbreaking solution in joint health supplementation—100% plant-based, vegetarian-friendly, low-dose, and fast-acting, designed to support joint health effectively.
Derived from
natural wheat
sources
Free from allergens,
ensuring no adverse
reactions or burdens
on the body
No genetically
modified ingredients,
ensuring safety
and purity
Available in various
product forms,
enhancing market
applicability and value
Effective at
a low dosage
of only 40 mg
per day
Vollapep2™ Product Solutions
Vollapep2™
Product Solutions
Vollapep2™ Minimize The Risk of Arthritis
Vollapep2™
Minimize The Risk of Arthritis
The mice were administered arthritis inducers on Day 0 and Day 21 to stimulate the development of arthritis. The results show that the experimental group of mice fed with Vollapep2™ had a significantly reduced chance of developing arthritis.
The mice were administered arthritis inducers on Day 0 and Day 21 to stimulate the development of arthritis. The results show that the experimental group of mice fed with Vollapep2™ had a significantly reduced chance of developing arthritis.
Vollapep2™ Reduce The Arthritis Index
Vollapep2™
Reduce The Arthritis Index
The mice were administered arthritis inducers on Day 0 and Day 21 to stimulate the development of arthritis. The results show that the experimental group of mice fed with Vollapep2™ had a significantly lower arthritis index.
The mice were administered arthritis inducers on Day 0 and Day 21 to stimulate the development of arthritis. The results show that the experimental group of mice fed with Vollapep2™ had a significantly lower arthritis index.
Vollapep2™ Relieve Arthritis Symptoms
Vollapep2™
Relieve Arthritis Symptoms
According to the experimental results, the symptoms of arthritis in the experimental group of mice fed with Vollapep2™ were significantly reduced and alleviated compared to the control group.
According to the experimental results, the symptoms of arthritis in the experimental group of mice fed with Vollapep2™ were significantly reduced and alleviated compared to the control group.
Vollapep2™ Assisting in Immune Regulation
Vollapep2™
Assisting in Immune Regulation
The experimental results indicate that the number of immunoglobulin antibody-secreting cells in the spleens of mice fed with Vollapep2™ was significantly lower compared to the control group, suggesting that Vollapep2™ has immune-regulating capabilities.
The experimental results indicate that the number of immunoglobulin antibody-secreting cells in the spleens of mice fed with Vollapep2™ was significantly lower compared to the control group, suggesting that Vollapep2™ has immune-regulating capabilities.
Applications & Formulations
Applications & Formulations
Applications & Formulations
Applications & Formulations
- Powder
Customized according to different needs, functions and flavor.
‧ Powder
Customized according to different needs, functions and flavor.
- Liquid
Functional drinks, fast absorption, high consumer acceptance.
‧ Liquid
Functional drinks, fast absorption, high consumer acceptance.
- Capsule
Enteric-coated, long-lasting, vegetarian and other capsule applications.
‧ Capsule
Enteric-coated, long-lasting, vegetarian and other capsule applications.
- Tablets
The most common dosage form used. Wide range of applications.
‧ Tablets
The most common dosage form used. Wide range of applications.
- Jelly/Gummy
The healthly snack market has grown rapidly. These products are favored by all ages and can increase the tendency of the people for healthy product intake.
‧ Jelly/Gummy
The healthly snack market has grown rapidly. These products are favored by all ages and can increase the tendency of the people for healthy product intake.
Link to: 聯絡我們
BECOME A PARTNER +
Professional R & D team to provide you with excellent solutions!
Link to: 聯絡我們
ASK FOR PRODUCT INFORMATION＋
Our R&D and production team has rich experience in functional food design, providing customers with more diverse application options.
Hansford Biotech Co., Ltd.
Tel: +886-4-22471738
Email: info@hansfordbio.com
Address: 11F., No. 46-10, Sec. 2, Chongde Rd., Beitun Dist., Taichung City 406503 , Taiwan
Tel:
+886-4-22471738
Email:
info@hansfordbio.com
Address:
11F., No. 46-10, Sec. 2, Chongde Rd., Beitun Dist., Taichung City 406503 , Taiwan
